Check out your Company Bowl for anonymous work chats.
The Global Work Standards Authority has recognized Novotech as one of "India's Best Workplaces for Women 2022." A workplace with equal opportunities, diversity, and inclusion has always been our goal. Thank you so much for this wonderful recognition, everyone! Find out more about opportunities at Novotech here: http://ow.ly/EStB50LhcNp #GPTW #bestplaceforwomen #diversityandinclusion #Novotech
We are delighted to join a prestigious group of global CROs as a finalist in the Scrip Award for Best Full-Service CRO. “The Award for the Best CRO acknowledges the critical role that CROs play in drug development. Outsourcing is vital as the pharmaceutical industry seeks to benefit more and more from these specialist companies’ experience in handling all aspects of clinical trials and other research”. Looking forward to the announcement in Royal Lancaster, London, in November
We are eagerly looking forward to another informative and insightful presentation from Kasey Kime, Director of Regulatory Affairs, Biodesk. “Regulatory Considerations for Plasmid DNA Vaccines” Kasey will present during the upcoming 10th Annual Biologics World Taiwan and Stem Cells & Regenerative Medicine Asia 2022 Wednesday, 19 October. Our Taiwan team will be present live during the conference at booth no 06, visit our team to find out more about how Asia Pacific emerging as the fastest growing region globally in clinical development and what makes Novotech the leading Asia Pacific biotech specialist CRO.
We are excited to be attending ESMO 2022 Congress in Paris, which will be held during September 09-13. ESMO 2022, the most anticipated oncology meeting of the year in Europe is an excellent platform to connect with key opinion leaders to discuss about the burning topics in the field of medical oncology.
As Asia Pacific’s leading Biotech specialist CRO we are committed to the expansion and support of early phase clinical research capabilities across the region. Thank you to Clinical Research Malaysia for hosting our CEO Dr John Moller on his recent visit.
Novotech is pleased to be supporting this significant event, BIOplus Interphex Korea 2022 from 03-05 August 2022 in Seoul, South Meet our experts during the event and find out more about our recent US services expansion and the benefits of bringing early and late phase clinical trials to the Asia Pacific region.
SK bioscience, a client of Novotech, earns SKYCOVIONE™ COVID-19 vaccine approval in Korea. Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the recent COVID-19 vaccine license approval.
We are extremely happy that the Best Workplace Flexibility Program has chosen Novotech as an Excellence Awardee in 2022 in recognition of our workplace flexibility efforts. We are a finalist for the "EXCELLENCE AWARD 2022" in the category for the best workplace flexibility program thanks to our flexible work policy.
Novotech receives “BEST BIOLOGICS CRO AWARD 2022” at Korea Bioprocessing Excellence Awards 2022. Seoul, South Korea - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today awarded the Best Biologics CRO Award at a ceremony as part of the 11th Biologics Manufacturing Korea, the 6th Cell & Gene Therapy World East Asia, and the 3rd BioLogistics World Korea conferences (29th – 30th June 2022) which attract more than 300 representatives from Korea’s top biopharma, vaccine manufacturers, and biologics companies.
Novotech receives CRO Leadership Award for exceeding customer expectations. Chicago - USA - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and Life Science Leader CRO Leadership Award for exceeding customer expectations, at Drug Information Association 2022 (DIA 2022).
